Netanel Derovan

Companies

• Oramed PharmaceuticalsGeneral counsel Jan 11, 2022 to May 31, 2023¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Oramed Pharmaceuticals ORMP149,500 shares²$609.9K at $4.08May 26, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• May 26, 2023Granted 20,500 shares of Oramed Pharmaceuticals²
• Apr 17, 2023Granted 81,000 shares of Oramed Pharmaceuticals³
• Jul 28, 2022Granted 30,000 shares of Oramed Pharmaceuticals⁴
• Jan 9, 2022Granted 18,000 shares of Oramed Pharmaceuticals⁵